BIOFRONTERA INC C/WTS 27/10/2026 (TO PUR COM) | 8-K: FY2026 Q1 Revenue: USD 10.08 MEarnings Watch·May 14 at 07:02 AMBFRIW+0.34%
Pre-announcement of a financial report according to articles 114 - 117 WpHGpressetext·Apr 17 at 03:50 PMB8F
BIOFRONTERA INC C/WTS 27/10/2026 (TO PUR COM) | 10-K: FY2025 Revenue: USD 41.71 MEarnings Watch·Mar 19 at 03:19 PMBFRIW+0.34%
Biofrontera reports rise in Q4 revenue, turns profitablebusinessinsider·Mar 19 at 02:27 PMB8FBFRIW+0.34%
BIOFRONTERA INC C/WTS 27/10/2026 (TO PUR COM) | 8-K: FY2025 Q4 Revenue: USD 17.1 MEarnings Watch·Mar 19 at 08:38 AMBFRIW+0.34%
Biofrontera Sets 2026 Guidance and Highlights Growing U.S. Earn-Out IncomeTip Ranks·Mar 10 at 01:28 PMIBB+0.57%BBH+0.29%
Biofrontera Reports Positive Phase 2b Acne Trial ResultsTip Ranks·Mar 9 at 08:49 AMXHE-1.10%IHI-0.82%
BIOFRONTERA INC C/WTS 27/10/2026 (TO PUR COM) | 8-K: FY2025 Q3 Revenue: USD 6.988 MEarnings Watch·Nov 13, 2025 at 07:33 AMBFRIW+0.34%
BIOFRONTERA INC C/WTS 27/10/2026 (TO PUR COM) | 8-K: FY2025 Q2 Revenue: USD 9.03 MEarnings Watch·Aug 13, 2025 at 04:23 PMBFRIW+0.34%
